Antibody injection promising for diabetes and obesity
(Medical Xpress) -- Researchers at Genetech Inc. in South San Francisco, California, led by molecular biologist Junichiro Sonoda, have discovered that a single injection of antibodies into obese diabetic mice provided a marked and sustained improvement in their condition and a reduction in their weight.
The research by Genetech, which is part of the Roche Group, targeted "brown fat," and the injections resulted in greater energy expenditure, lowered blood sugar, and reduced fat in the livers of the mice. Researcher Dr. Sonoda said the results were unprecedented, with the drug removing liver fat, which improves the disease conditions.
Brown fat is a specialized kind of fat (adipose tissue) that burns energy to keep the body warm, rather than storing it for future energy needs. Independent studies by three groups of scientists in 2009 found that adult bodies have small amounts of brown fat, primarily around the shoulder blades, the spine, and in the neck. Until this research it had been assumed that brown fat was only found in babies.
The finding of brown adipose tissue in adults led to the idea that if the brown fat could be activated, people might lose weight through burning more calories, and this could reduce the levels of obesity and associated conditions such as type 2 diabetes.
Studies have shown that the hormone fibroblast growth factor 21 (FGF21) activates brown fat, and it has been shown to reduce blood triglycerides and to normalize blood sugar levels in mice. Early attempts to use recombinant FGF21 as a drug failed because it is cleared from the bloodstream in only a few hours, giving it little chance to operate.
The new study began by making antibodies to bind to the FGF21 receptors. Dr Sonoda said that one of these receptors was FGFR1, which increased the expression of a number of genes involved in energy expenditure. FGFR1 is found in fat tissues and in the pancreas.
In other cases where antibodies are used as drugs they inhibit the receptors, but in this case the aim was to stimulate the receptors instead to make them mimic the effects of FGF21. Dr Sonoda said the results obtained in mice were better than expected, with one injection into the diabetic, obese mice normalizing blood sugar levels after a week, and the levels remained low for up to a month, with no apparent side effects. The mice also lost around 10% of their body weight during the period.
In type 2 diabetes there is insufficient insulin in the bloodstream to extract sugar and deliver it to cells where its energy is required. This leads to increased blood sugar levels, which can damage various organs in the body. A link between the fibroblast growth factor and diabetes had been identified in mice previously, but so far tests in humans have been unsuccessful.
A drug based on the research is not expected to be available for many years, and no date has been announced for the beginning of clinical trials.
The paper was published in the journal Science Translational Medicine on December 14th.
More information: Amelioration of Type 2 Diabetes by Antibody-Mediated Activation of Fibroblast Growth Factor Receptor 1, Sci Transl Med 14 December 2011: Vol. 3, Issue 113, p. 113ra126, DOI:10.1126/scitranslmed.3002669
Clinical use of recombinant fibroblast growth factor 21 (FGF21) for the treatment of type 2 diabetes and other disorders linked to obesity has been proposed; however, its clinical development has been challenging owing to its poor pharmacokinetics. Here, we describe an alternative antidiabetic strategy using agonistic anti-FGFR1 (FGF receptor 1) antibodies (R1MAbs) that mimic the metabolic effects of FGF21. A single injection of R1MAb into obese diabetic mice induced acute and sustained amelioration of hyperglycemia, along with marked improvement in hyperinsulinemia, hyperlipidemia, and hepatosteatosis. R1MAb activated the mitogen-activated protein kinase pathway in adipose tissues, but not in liver, and neither FGF21 nor R1MAb improved glucose clearance in lipoatrophic mice, which suggests that adipose tissues played a central role in the observed metabolic effects. In brown adipose tissues, both FGF21 and R1MAb induced phosphorylation of CREB (cyclic adenosine 5′-monophosphate response elementbinding protein), and mRNA expression of PGC-1α (peroxisome proliferatoractivated receptor-γ coactivator 1α) and the downstream genes associated with oxidative metabolism. Collectively, we propose FGFR1 in adipose tissues as a major functional receptor for FGF21, as an upstream regulator of PGC-1α, and as a compelling target for antibody-based therapy for type 2 diabetes and other obesity-associated disorders.
Journal reference: Science Translational Medicine
© 2011 Medical Xpress
- Mother's milk turns on the heat Mar 02, 2010 | not rated yet | 0
- Orexin: A hormone that fights fat with fat Oct 04, 2011 | not rated yet | 0
- Calorie-burning brown fat is a potential obesity treatment, researchers say Jun 06, 2011 | not rated yet | 0
- Control of blood vessels a possible weapon against obesity Jan 07, 2009 | not rated yet | 0
- Starvation hormone makes for small mice Jun 26, 2008 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013 Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
By discovering the new mechanism by which estrogen suppresses lipid synthesis in the liver, UC Irvine endocrinologists have revealed a potential new approach toward treating certain liver diseases.
Medical research May 23, 2013 | not rated yet | 0 |
Aortic arch pulse wave velocity, a measure of arterial stiffness, is a strong independent predictor of disease of the vessels that supply blood to the brain, according to a new study published in the June issue the journal ...
Medical research May 23, 2013 | not rated yet | 0
Since the discovery of Prontosil in 1932, sulfonamide antibiotics have been used to combat a wide spectrum of bacterial infections, from acne to chlamydia and pneumonia. However, their side effects can include serious neurological ...
Medical research May 23, 2013 | not rated yet | 0 |
Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as ...
Medical research May 23, 2013 | 5 / 5 (3) | 0 |
Spanish researchers have discovered that the daily clearance of neutrophils from the body stimulates the release of hematopoietic stem cells from the bone marrow into the bloodstream, according to a report published today ...
Medical research May 23, 2013 | 5 / 5 (2) | 0
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
5 hours ago | 5 / 5 (1) | 0 |
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
11 hours ago | 5 / 5 (3) | 0 |
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
8 hours ago | 5 / 5 (1) | 0 |
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
8 hours ago | 5 / 5 (2) | 0 |
Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.
5 hours ago | not rated yet | 0
Kate O'Reilly's spring allergy survival kit includes the usual stuff - nasal sprays, allergy pills and a box of tissues. This season, she's added a new weapon to her line of defense: an app on her smartphone.
6 hours ago | not rated yet | 0